WASHINGTON, June 11 -- Food and Drug Administration has issued a notice called: Drug Repurposing for Unmet Medical Needs; Request for Information; Extension of Comment Period.
The notice was published in the Federal Register on June 11 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA, the Agency, or we) is extending the comment period for the notice entitled "Drug Repurposing for Unmet Medical Needs; Request for Information" that appeared in the Federal Registerof May 12, 2026 (91 FR 25897). In the notice, FDA requested comments to solicit input on FDA's efforts with respect to drug repurposing to address unmet medical needs. The Agency is taking thi...